HCPCS codes:M

• M0064 - Brief office visit for the sole purpose of monitoring or changing drug prescriptions used in the treatment of mental psychoneurotic and personality disorders.
• M0075 - Cellular therapy.
• M0076 - Prolotherapy.
• M0100 - Intragastric hypothermia using gastric freezing.
• M0300 - Iv chelation therapy (chemical endarterectomy).
• M0301 - Fabric wrapping of abdominal aneurysm.
• M1000 - Pain screened as moderate to severe.
• M1001 - Plan of care to address moderate to severe pain documented on or before the date of the second visit with a clinician.
• M1002 - Plan of care for moderate to severe pain not documented on or before the date of the second visit with a clinician, reason not given.
• M1003 - Tb screening performed and results interpreted within twelve months prior to initiation of first-time biologic disease modifying anti-rheumatic drug therapy for ra.
• M1004 - Documentation of medical reason for not screening for tb or interpreting results (i.e., patient positive for tb and documentation of past treatment; patient who has recently completed a course of anti-tb therapy).
• M1005 - Tb screening not performed or results not interpreted, reason not given.
• M1006 - Disease activity not assessed, reason not given.
• M1007 - more than=50% of total number of a patient's outpatient ra encounters assessed.
• M1008 - less than50% of total number of a patient's outpatient ra encounters assessed.
• M1009 - Patient treatment and final evaluation complete.
• M1010 - Patient treatment and final evaluation complete.
• M1011 - Patient treatment and final evaluation complete.
• M1012 - Patient treatment and final evaluation complete.
• M1013 - Patient treatment and final evaluation complete.
• M1014 - Patient treatment and final evaluation complete.
• M1015 - Patient treatment and final evaluation complete.
• M1016 - Female patients unable to bear children.
• M1017 - Patient admitted to palliative care services.
• M1018 - Patients with an active diagnosis or history of cancer (except basal cell and squamous cell skin carcinoma), patients who are heavy tobacco smokers, lung cancer screening patients.
• M1019 - Adolescent patients 12 to 17 years of age with major depression or dysthymia who reached remission at twelve months as demonstrated by a twelve month (+--60 days) phq-9 or phq-9m score of less than 5.
• M1020 - Adolescent patients 12 to 17 years of age with major depression or dysthymia who did not reach remission at twelve months as demonstrated by a twelve month (+--60 days) phq-9 or phq-9m score of less than 5. either phq-9 or phq-9m score was not assessed or is greater than or equal to 5.
• M1021 - Patient had only urgent care visits during the performance period.
• M1022 - Patients who were in hospice at any time during the performance period.
• M1023 - Adolescent patients 12 to 17 years of age with major depression or dysthymia who reached remission at six months as demonstrated by a six month (+--60 days) phq-9 or phq-9m score of less than five.
• M1024 - Adolescent patients 12 to 17 years of age with major depression or dysthymia who did not reach remission at six months as demonstrated by a six month (+--60 days) phq-9 or phq-9m score of less than five. either phq-9 or phq-9m score was not assessed or is greater than or equal to five.
• M1025 - Patients who were in hospice at any time during the performance period.
• M1026 - Patients who were in hospice at any time during the performance period.
• M1027 - Imaging of the head (ct or mri) was obtained.
• M1028 - Documentation of patients with primary headache diagnosis and imaging other than ct or mri obtained.
• M1029 - Imaging of the head (ct or mri) was not obtained, reason not given.
• M1030 - Patients with clinical indications for imaging of the head.
• M1031 - Patients with no clinical indications for imaging of the head.
• M1032 - Adults currently taking pharmacotherapy for oud.
• M1033 - Pharmacotherapy for oud initiated after june 30th of performance period.
• M1034 - Adults who have at least 180 days of continuous pharmacotherapy with a medication prescribed for oud without a gap of more than seven days.
• M1035 - Adults who are deliberately phased out of medication assisted treatment (mat) prior to 180 days of continuous treatment.
• M1036 - Adults who have not had at least 180 days of continuous pharmacotherapy with a medication prescribed for oud without a gap of more than seven days.
• M1037 - Patients with a diagnosis of lumbar spine region cancer at the time of the procedure.
• M1038 - Patients with a diagnosis of lumbar spine region fracture at the time of the procedure.
• M1039 - Patients with a diagnosis of lumbar spine region infection at the time of the procedure.
• M1040 - Patients with a diagnosis of lumbar idiopathic or congenital scoliosis.
• M1041 - Patient had cancer, fracture or infection related to the lumbar spine or patient had idiopathic or congenital scoliosis.
• M1042 - Functional status measurement with score was obtained utilizing the oswestry disability index (odi version 2.1a) patient reported outcome tool within three months preoperatively and at one year (9 to 15 months) postoperatively.
• M1043 - Functional status measurement with score was not obtained utilizing the oswestry disability index (odi version 2.1a) patient reported outcome tool within three months preoperatively and at one year (9 to 15 months) postoperatively.
• M1044 - Functional status was measured by the oswestry disability index (odi version 2.1a) patient reported outcome tool within three months preoperatively and at one year (9 to 15 months) postoperatively.
• M1045 - Functional status measurement with score was obtained utilizing the oxford knee score (oks) patient reported outcome tool within three months preoperatively and at one year (9 to 15 months) postoperatively.
• M1046 - Functional status measurement with score was not obtained utilizing the oxford knee score (oks) patient reported outcome tool within three months preoperatively and at one year (9 to 15 months) postoperatively.
• M1047 - Functional status was measured by the oxford knee score (oks) patient reported outcome tool within three months preoperatively and at one year (9 to 15 months) postoperatively.
• M1048 - Functional status measurement with score was obtained utilizing the oswestry disability index (odi version 2.1a) patient reported outcome tool within three months preoperatively and at three months (6 to 20 weeks) postoperatively.
• M1049 - Functional status measurement with score was not obtained utilizing the oswestry disability index (odi version 2.1a) patient reported outcome tool within three months preoperatively and at three months (6 to 20 weeks) postoperatively.
• M1050 - Functional status was measured by the oswestry disability index (odi version 2.1a) patient reported outcome tool within three months preoperatively and at three months (6 to 20 weeks) postoperatively.
• M1051 - Patient had cancer, fracture or infection related to the lumbar spine or patient had idiopathic or congenital scoliosis.
• M1052 - Leg pain was not measured by the visual analog scale (vas) within three months preoperatively and at one year (9 to 15 months) postoperatively.
• M1053 - Leg pain was measured by the visual analog scale (vas) within three months preoperatively and at one year (9 to 15 months) postoperatively.
• M1054 - Patient had only urgent care visits during the performance period.
• M1055 - Aspirin or another antiplatelet therapy used.
• M1056 - Prescribed anticoagulant medication during the performance period, history of gi bleeding, history of intracranial bleeding, bleeding disorder and specific provider documented reasons: allergy to aspirin or anti-platelets, use of non-steroidal anti-inflammatory agents, drug-drug interaction, uncontrolled hypertension more than 180-110 mmhg or gastroesophageal reflux disease.
• M1057 - Aspirin or another antiplatelet therapy not used, reason not given.
• M1058 - Patient was a permanent nursing home resident at any time during the performance period.
• M1059 - Patient was in hospice or receiving palliative care at any time during the performance period.
• M1060 - Patient died prior to the end of the performance period.
• M1061 - Patient pregnancy.
• M1062 - Patient immunocompromised.
• M1063 - Patients receiving high doses of immunosuppressive therapy.
• M1064 - Shingrix vaccine documented as administered or previously received.
• M1065 - Shingrix vaccine was not administered for reasons documented by clinician (e.g. patient administered vaccine other than shingrix, patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons).
• M1066 - Shingrix vaccine not documented as administered, reason not given.
• M1067 - Hospice services for patient provided any time during the measurement period.
• M1068 - Adults who are not ambulatory.
• M1069 - Patient screened for future fall risk.
• M1070 - Patient not screened for future fall risk, reason not given.
• M1071 - Patient had any additional spine procedures performed on the same date as the lumbar discectomy-laminotomy.
• M2 - Medicare secondary payer (msp).
• MS - Six month maintenance and servicing fee for reasonable and necessary parts and labor which are not covered under any manufacturer or supplier warranty.

HCPCS codes
HCPCS codes starting with A - B - C - D - E - F - F - G - H - I - J - K - L - M - N - O - P - Q - R - S - T - U - V - W - X - Y - Z

External links

• HCPCS by the AAPC
• HCPCS Complete Reference
• HCPCS Level 2 codes 2020